Work-related threats and violence and post-traumatic symptoms in four high-risk occupations: short- and long-term symptoms

2018 ◽  
Vol 92 (2) ◽  
pp. 195-208 ◽  
Author(s):  
Lars Peter Andersen ◽  
Annie Hogh ◽  
Ask Elklit ◽  
Johan Hviid Andersen ◽  
Karin Biering
2007 ◽  
Vol 13 (5) ◽  
pp. 358-368 ◽  
Author(s):  
Gwen Adshead ◽  
Scott Ferris

Not all traumatic events cause post-traumatic stress disorder (PTSD), and people develop PTSD symptoms after events that do not seem to be overwhelmingly traumatic. In order to direct services appropriately, there is a need to distinguish time-limited post-traumatic symptoms and acute stress reactions (that may improve spontaneously without treatment or respond to discrete interventions) from PTSD, with its potentially more chronic pathway and possible long-term effects on the personality. In this article, we describe acute and chronic stress disorders and evidence about the most effective treatments.


Hand Surgery ◽  
2001 ◽  
Vol 06 (01) ◽  
pp. 1-11 ◽  
Author(s):  
Bruce R. Johnstone

A consecutive series of 20 joints in 13 patients underwent arthroplasty with the RMS PIP joint surface replacement implant. Twelve joints were treated for painful osteoarthritis (all females). Two joints were implanted for rheumatoid arthritis, two for post-traumatic pain and stiffness, two for post-traumatic stiffness and one each for post-traumatic pain and pain-free post-traumatic instability. Excellent, often total long-term pain relief was obtained in 18 joints. The other two patients with (compensible work-related) post-traumatic pain and stiffness reported "50–70% pain reduction". No patients lost movement and 14 out of 20 joints were pain-free with a 73.1° average arc of motion. Six joints from the first half of the series had poor motion (average arc of 19.6°), even after open extensor tenolysis or manipulation under anaesthesia. As experience was gained, reliably better results were achieved with a more intensive regimen of hand therapy, particularly within the first post-operative week.


1998 ◽  
Vol 19 (12) ◽  
pp. 1802-1807 ◽  
Author(s):  
M. Möckel ◽  
T. Störk ◽  
G. Heller ◽  
L. Röcker ◽  
O. Danne ◽  
...  

Author(s):  
Kevin C De Braganca ◽  
Roger J Packer

Medulloblastoma is the most common malignant brain tumor in pediatric patients. Patients are presently stratified to either standard or high-risk groups based on clinical and pathologic criteria. Approximately 80% of patients with standard risk disease are cured of their primary disease. High-risk and recurrent disease groups have a poorer outcome; 5-year progression-free survival is only 65% with high-risk disease. Disease control after recurrence is very poor. Treatment is multimodal and also aims to limit short- and long-term toxicities. Recent identification of four molecular subtypes of medulloblastoma may change risk assignment and therapy. Addressing the medical and psychosocial issues of survivors continues to improve the quality of life for these patients beyond the disease’s treatment.


Children ◽  
2019 ◽  
Vol 6 (1) ◽  
pp. 5 ◽  
Author(s):  
Holly J. Meany

Neuroblastoma, a tumor of the sympathetic nervous system, is the most common extra-cranial neoplasm of childhood. Variables with prognostic significance in patients with neuroblastoma, including age at diagnosis, disease stage, tumor histology, MYCN gene amplification, tumor cell ploidy, and the presence of segmental chromosomal aberrations are utilized to classify patients based on risk of disease recurrence. Patients with non-high-risk neuroblastoma, low- and intermediate-risk categories, represent nearly half of all newly diagnosed cases. This group has an excellent event-free and overall survival with current therapy. Over time, the objective in treatment of non-high-risk neuroblastoma has been reduction of therapy intensity to minimize short- and long-term adverse events all the while maintaining excellent outcomes.


Work ◽  
2020 ◽  
Vol 65 (3) ◽  
pp. 573-580
Author(s):  
Lars Peter Andersen ◽  
Karin Biering ◽  
Annie Hogh ◽  
Charlotte Ann Gadegaard ◽  
Paul Maurice Conway

Sign in / Sign up

Export Citation Format

Share Document